Annual Total Liabilities
$1.83 M
-$8800.00-0.48%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual total liabilities is $1.83 million, with the most recent change of -$8800.00 (-0.48%) on September 30, 2024.
- During the last 3 years, EDSA annual total liabilities has risen by +$306.40 thousand (+20.07%).
- EDSA annual total liabilities is now -82.89% below its all-time high of $10.71 million, reached on August 31, 2013.
Performance
EDSA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.83 M
-$527.80 K-22.36%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly total liabilities is $1.83 million, with the most recent change of -$527.80 thousand (-22.36%) on September 30, 2024.
- Over the past year, EDSA quarterly total liabilities has dropped by -$317.90 thousand (-14.78%).
- EDSA quarterly total liabilities is now -82.89% below its all-time high of $10.71 million, reached on August 31, 2013.
Performance
EDSA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EDSA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.5% | -14.8% |
| 3 y3 years | +20.1% | +16.8% |
| 5 y5 years | +297.1% | +16.8% |
EDSA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.1% | +20.1% | -67.9% | +30.8% |
| 5 y | 5-year | -55.6% | +297.1% | -67.9% | +161.2% |
| alltime | all time | -82.9% | -100.0% | -82.9% | -100.0% |
Edesa Biotech Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $1.83 M(-0.5%) | $1.83 M(-22.4%) |
| Jun 2024 | - | $2.36 M(+9.8%) |
| Mar 2024 | - | $2.15 M(+8.2%) |
| Dec 2023 | - | $1.99 M(+7.9%) |
| Sep 2023 | $1.84 M(-15.7%) | $1.84 M(+17.4%) |
| Jun 2023 | - | $1.57 M(-6.2%) |
| Mar 2023 | - | $1.67 M(+19.4%) |
| Dec 2022 | - | $1.40 M(-35.8%) |
| Sep 2022 | $2.18 M(+43.1%) | $2.18 M(-61.7%) |
| Jun 2022 | - | $5.70 M(+68.6%) |
| Mar 2022 | - | $3.38 M(+88.6%) |
| Dec 2021 | - | $1.79 M(+17.5%) |
| Sep 2021 | $1.53 M(-63.1%) | $1.53 M(+42.2%) |
| Jun 2021 | - | $1.07 M(-77.3%) |
| Mar 2021 | - | $4.73 M(+96.6%) |
| Dec 2020 | - | $2.41 M(-41.8%) |
| Sep 2020 | $4.13 M(+795.0%) | $4.13 M(+15.4%) |
| Jun 2020 | - | $3.58 M(+410.3%) |
| Mar 2020 | - | $701.70 K(-18.0%) |
| Dec 2019 | - | $855.70 K(-15.7%) |
| Sep 2019 | $461.60 K(-6.4%) | - |
| Jun 2019 | - | $1.01 M(+15.2%) |
| Mar 2019 | - | $881.40 K(+48.9%) |
| Dec 2018 | - | $592.00 K(+20.0%) |
| Sep 2018 | $493.40 K(+53.8%) | $493.40 K(+19.0%) |
| Jun 2018 | - | $414.60 K(-29.7%) |
| Mar 2018 | - | $589.80 K(+2.7%) |
| Dec 2017 | - | $574.40 K(+79.0%) |
| Sep 2017 | $320.90 K | $320.90 K(-24.5%) |
| Jun 2017 | - | $425.30 K(-1.9%) |
| Mar 2017 | - | $433.40 K(-28.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | - | $602.10 K(-3.4%) |
| Sep 2016 | $623.60 K(-73.8%) | $623.60 K(-25.7%) |
| Jun 2016 | - | $839.00 K(+36.2%) |
| Mar 2016 | - | $616.10 K(-14.9%) |
| Dec 2015 | - | $723.70 K(-69.6%) |
| Sep 2015 | $2.38 M(-45.4%) | $2.38 M(+33.7%) |
| Jun 2015 | - | $1.78 M(-38.7%) |
| Mar 2015 | - | $2.90 M(-30.7%) |
| Dec 2014 | - | $4.19 M(-38.2%) |
| Sep 2014 | $4.36 M(-35.6%) | - |
| Aug 2014 | $6.77 M(-36.8%) | $6.77 M(+55.6%) |
| May 2014 | - | $4.35 M(-41.2%) |
| Feb 2014 | - | $7.40 M(-18.1%) |
| Nov 2013 | - | $9.04 M(-15.6%) |
| Aug 2013 | $10.71 M(+1446.9%) | $10.71 M(+100.1%) |
| May 2013 | - | $5.35 M(+16.4%) |
| Feb 2013 | - | $4.60 M(+211.4%) |
| Nov 2012 | - | $1.48 M(+113.2%) |
| Aug 2012 | $692.30 K(-59.0%) | $692.30 K(+42.7%) |
| May 2012 | - | $485.10 K(-27.8%) |
| Feb 2012 | - | $672.30 K(-41.0%) |
| Nov 2011 | - | $1.14 M(-32.5%) |
| Aug 2011 | $1.69 M(+38.5%) | $1.69 M(+1172.8%) |
| May 2011 | - | $132.50 K(-1.1%) |
| Feb 2011 | - | $134.00 K(-71.2%) |
| Nov 2010 | - | $464.90 K(-61.8%) |
| Aug 2010 | $1.22 M(>+9900.0%) | $1.22 M(+968.3%) |
| May 2010 | - | $114.00 K(+125.7%) |
| Jan 2010 | - | $50.50 K(+268.6%) |
| Oct 2009 | - | $13.70 K(>+9900.0%) |
| Apr 2009 | $0.00(-100.0%) | $0.00 |
| Apr 2008 | $9400.00 | - |
FAQ
- What is Edesa Biotech annual total liabilities?
- What is the all time high annual total liabilities for Edesa Biotech?
- What is Edesa Biotech annual total liabilities year-on-year change?
- What is Edesa Biotech quarterly total liabilities?
- What is the all time high quarterly total liabilities for Edesa Biotech?
- What is Edesa Biotech quarterly total liabilities year-on-year change?
What is Edesa Biotech annual total liabilities?
The current annual total liabilities of EDSA is $1.83 M
What is the all time high annual total liabilities for Edesa Biotech?
Edesa Biotech all-time high annual total liabilities is $10.71 M
What is Edesa Biotech annual total liabilities year-on-year change?
Over the past year, EDSA annual total liabilities has changed by -$8800.00 (-0.48%)
What is Edesa Biotech quarterly total liabilities?
The current quarterly total liabilities of EDSA is $1.83 M
What is the all time high quarterly total liabilities for Edesa Biotech?
Edesa Biotech all-time high quarterly total liabilities is $10.71 M
What is Edesa Biotech quarterly total liabilities year-on-year change?
Over the past year, EDSA quarterly total liabilities has changed by -$317.90 K (-14.78%)